HARVARD BIOSCIENCE INC 8-K

What Happened
Harvard Bioscience, Inc. announced on January 12, 2026 (Form 8‑K) that it distributed an investor update slide presentation to the investment community under Regulation FD. The slide deck, titled "Harvard Bioscience, Inc. Investor Update," is attached to the filing as Exhibit 99.1 and is incorporated by reference into the Form 8‑K.

Key Details

• Filing date: January 12, 2026 (Form 8‑K, Item 7.01 Regulation FD Disclosure).
• Exhibit: 99.1 — "Harvard Bioscience, Inc. Investor Update," dated January 12, 2026.
• The company states it periodically presents/distributes slide presentations at industry and other conferences about its business strategy and outlook.
• The filing does not report earnings, financial results, or management changes.

Why It Matters
An investor update slide deck can provide refreshed commentary on Harvard Bioscience’s business strategy, outlook, and recent developments that may be useful to shareholders and potential investors. Because the information was disclosed under Regulation FD and attached to the 8‑K, it ensures broad, public access to the same materials the company shares with analysts and conference attendees. Note that this filing does not itself contain financial results or executive changes.